| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $371.5M | +22.0% |
| Cost of Revenue | $92.3M | +12.8% |
| Gross Profit | $279.2M | +25.4% |
| R&D Expense | $113.1M | +12.0% |
| SG&A Expense | $60.7M | +15.5% |
| Operating Income | -$8.0M | +73.4% |
| Pre-tax Income | -$4.6M | +83.2% |
| Income Tax | -$71K | -111.5% |
| Net Income | -$4.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $159.2M | +130.9% |
| Accounts Receivable | $58.0M | +37.5% |
| Inventory | $8.1M | +96.6% |
| Current Assets | $241.0M | +83.4% |
| Total Assets | $441.6M | +37.3% |
| Current Liabilities | $77.3M | +9.2% |
| Total Liabilities | $83.0M | +11.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.6M | +333.4% |
| Capital Expenditures | $1.2M | +134.6% |
| Investing Cash Flow | -$10.1M | -356.2% |
| Financing Cash Flow | $67.3M | +369.5% |
| Free Cash Flow | $31.4M | +347.8% |
| +83.8% |
| EPS (Basic) | -$0.06 | +85.7% |
| EPS (Diluted) | -$0.06 | +85.7% |
| Stockholders' Equity |
| $358.5M |
| +45.1% |